Learning from Cochrane systematic reviews: what improvements do these suggest for the design of trials?

F1000Research

Volumn 9, Issue , 2020, Pages 178-

  Pirosca, Stefania ^a   Clarke, Mike ^b   Treweek, Shaun ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Multiple sclerosis.; Randomised controlled trial; Schizophrenia; Systematic reviews; Trial methodology

Indexed keywords

CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA;

CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SCHIZOPHRENIA; SYSTEMATIC REVIEWS AS TOPIC;

EID: 85102018678     PISSN: None     EISSN: 20461402     Source Type: Journal    
DOI: 10.12688/f1000research.22635.2     Document Type: Article

References (0)